Inhibition of monoamine oxidase by higenamine

Medical Science Research

Volumn 27, Issue 1, 1999, Pages 71-72

  Lee, Sang Sun ^a   Yun Choi, Hye Sook ^a   Kim, Eung I I ^a   Lee, Myung Koo ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Benzylisoquinoline alkaloid; Brain; Higenamine; Kynuramine; Monoamine oxidase

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMINE OXIDASE (FLAVIN CONTAINING); BENZYLISOQUINOLINE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; HIGENAMINE;

ANIMAL TISSUE; AORTA; ARTICLE; BRAIN; CATABOLISM; CONTROLLED STUDY; DOPAMINE METABOLISM; ENZYME INHIBITION; HEART ATRIUM; MALE; MOUSE; NONHUMAN; PHEOCHROMOCYTOMA CELL;

EID: 0032902527     PISSN: 02698951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Tiplon KF. O'Carroll AM. McCrodden JM. The catalytic behavior of monoatninc oxidase. J Neural Tninxm (Suppl) 1987: 23:25-35.
2. Cesura AM. Kettler R, Itnhof R. DaPruda M. Mode of action and characteristics of monoatnine oxidase-A inhibition by moclobemide. Psychopharmacol 1992; 106:15-16.
3. Birkmayer W. Birkmayer GJ. Strategy and tactic of modern Parkinson therapy. Actci Neuml Scant! ISuppl) 1989: 126:63-66.
4. Bembenek ME. Abell CW. Chrisey LA, Ro/wadowska MD, Gessner W, Brossi A. Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2.3.4-tetrahydro-, 3,4-dihydro- and fully aromatic isoquinolines. J Med Chem 1990: 33:147-152.
5. Strolin-Benedetti M. Dosiert PL. Overview of the present state of MAO inhibitors. ./Neural Transm (Suppi) 1987; 23:103-119.
6. MaJ.ouz F, Gueddari S. Burstein C, Mansuy D. Milcent R. 5-(4ben/yloxyphenyl)-l,3.4-oxadiazol-2(3H)-one derivatives and related analogues: new reversible, highly potent, and selective monoamine oxidase type B inhibitors. J Med Chem 1993: 36:1157-1167.
7. White HL, Scales P. Mechanism of monoamine oxidase-A inhibition by BW 137ÜU87. Drug Dev Res 1992; 25:191-199.
8. Suzuki O, Katsumata Y, Oya M, Chari VM, Vermes B, Wagner H. et al. Inhibition of type A and type B monoamine oxidases by naturally occurring xanthones. Planta Med 1981; 42:17-21.
9. Thull U. Testa B. Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases. Biochem Pharmacol 1994: 47:2307-2310.
10. Giovine A, Renis M. Bertolino A. In vivo and in vitro studies on the effect of tetrahydropapaveroline and salsolinol on COMT and MAO activity in rat brain. Pharmacol 1976; 14:86-94.
11. Naoi M, Takahashi T, Darrez H, Kabeya R. Taguchi E. NMethylisoquinolinim ion as an inhibitor of tyrosine hydroxylase, aromatic L-amino acid decarboxylase and monoamine oxidase. Neumchemlnt 1989: 15:315-320.
12. Naoi M, Nagatsu T. Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds. J Neumchem 1988; 50:1105-1110,
13. Kimura I, Makino M. Takamura Y, Islam MA, Kimura M. Positive chronotropic and inotropic effects of higenamine and its enhancing action on the aconitine-induced tachyarrhythmia in isolated murine atria. Jap J Pharmacol 1994; 66:75-80.
14. Park CW, Chang KC, Lim JK. Effects of higenamine on isolated heart adrenoreceptor of rabbit. Arch Int Pharmacodyn 1984; 267:279-288.
15. Chang KC. Yun-Choi HS, Lim JK, Park CW. Synthesis of higenamine; A cardiotonic principle of Aconite root. Arch Pharm Res 1984; 7:133136.
16. Krajl M. A rapid microfluormetric determination of monoamine oxidase. Biochem Pharmacol 1965; 14:1683-1685.
17. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Bial Chem 1951; 193:265-275.
18. Suh YH. Park HY, Lim JK, Park CW. Effects of higenamine and its derivatives on the activity of rat brain mitochondria! monoamine oxidase. Kor J Pharmacol 1984; 20:73-79.
19. Chang KC, Chong WS, Lee IJ. Different pharmacological characteristics of structurally similar benzylisoquinoline analogs, papaverine, higenamine, and GS 389. on isolated rat aorta and heart. Can J Physio! Pharmacol 1994: 72:327-334.
20. Shin JS. Yun-Choi HS, Kim EI, Lee MK. Inhibitory effects of higenamine on dopamine content in PC12 cells. Planta Med 1998: submitted.